<DOC>
	<DOC>NCT00543959</DOC>
	<brief_summary>A study to evaluate the effectiveness and tolerability of MK0533 and pioglitazone in patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Patients between the ages of 18 to 70 years with Type 2 diabetes who have not been able to adequately control their blood glucose levels Note: Only patients who have not been taking any antihyperglycemic medicine for 3 months will be screened Patients taking any medicines that affect body fluid level such as a diuretic or water pill Patients taking niacin or other certain medications Patients with any of the following conditions: liver or kidney disease, poorly controlled high blood pressure, heart disease or certain blood disorders Patients with abnormal laboratory results from a blood test that will be given before each patient starts the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>